Contact Information

Please direct any questions regarding Medical Templates, MedSpel, ProfileMD Classic, GenericMedList, or this web site to

Please direct  questions related to the sale or delivery of MedSpel or a MedicalTemplate after purchase to RegNow, our e-commerce provider.

Last Modified 1/5/2009


Interstital Lung Disease Evaluation Medical Note Template

The interstitial lung disease evaluation MedicalTemplate is suitable for any health care provider who may evaluate a patient with interstitial lung disease.  

How to use MedicalTemplates


    Read this document on Scribd: Interstitial Lung Disease Evaluation

    Interstitial Lung Disease Evaluation Referring Physician Reason for consult History of Present Illness Date Start time PCP Stop time MRN Allergies ‰Patient is Nonverbal. History obtained from _______________________ ‰ Allergies reviewed ‰ No drug allergies ‰ No food allergies ‰Chronic, progressive dyspnea over >/= 1 year ‰Chronic cough with or without phlegm production ‰History of fever, chills, nightsweats, myalgias, arthralgias ‰Fatigue, chronic and progressive over same period as dyspnea ‰Increased interstitial markings seen or documented radiographically on >/= 2 occasions, 1 month apart and not related to renal or heart failure ‰History of medication use NSAIDs, amiodarone, methotrexate, gold, azathioprine, cyclophosphamide, penicillamine, flecainide, mexillitine, nitrofurantoin, paclitaxel, isoniazid, tetracycline, sulfa drugs, L-tryptophan, inhaled pentamidine, bleomycin, mitomycin C, chlorambucil Review of Systems See HPI WNL Medications Fatigue, malaise, fever/chills, weight loss, change in appetite Vision changes, New pain, Scotomas Nose bleeds, dental caries, dental abscesses, jaw pain Dyspnea, Cough, Phlegm, Hemoptysis, Wheeze, Apnea, Excessive daytime sleepiness, Hypnagogic/Hypnopompic Sx Chest pain, diaphoresis, ankle edema, PND, syncope Emesis, dysphagia, GERD, abdominal pain, diarrhea, melena Change in urinary habits, hematuria, dysuria Myalgias, recent trauma, bony fractures, arthralgias, joint swelling Rashes, nonhealing areas, new masses or skin lesions, increased sensitivity to sun exposure New paresthesias, seizures, chronic muscle weakness or episodic weakness associated with strong emotions Hair loss, polydipsia Bleeding gums, unusual bruising, swollen lymph nodes Sinus probs, recurrent infections Mood changes, agitation, psychosis, delirium, dementia ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ ‰ Constitutional Eyes ENT/mouth Resp CV GI GU Musc Skin/breasts Neuro Endo Heme/lymph Allergy/Immun Psych ‰ Medications reviewed Past Medical, Surgical and Social History ‰ Asthma ‰ Bronchiectasis ‰ COPD ‰ COP (aka BOOP) ‰ Cystic Fibrosis ‰ Histiocytosis ‰ Tuberculosis ‰ Pulmonary Hypertension ‰ Sarcoidosis ‰ Tuberculosis ‰ Wegener’s Granulomatosis ‰ Pulmonary Alveolar Proteinosis ‰ Narcolepsy ‰ Obstructive Sleep Apnea ‰ Restless Legs Syndrome ‰ Cerebral Artery Disease ‰ Congestive Heart Failure ‰ Coronary Artery Disease ‰ Diabetes ‰Type I ‰Type II ‰ GERD ‰ Hepatic Dysfunction ‰ HIV/AIDS ‰ Hypertension ‰ Inflammatory bowel disease ‰ Malignancy ‰ ARDS ‰ Neuromuscular weakness ‰ Occupational exposures ‰ Pancreatitis ‰ Peripheral Artery Disease ‰ Scleroderma ‰ Seizure Disorder ‰ Sjogren ‰ Renal Dysfunction ‰ Rheumatoid arthritis ‰ Thrombotic Disease ‰ Thyroid Disease ‰ Chemotherapy ‰ Colonoscopy ‰ ECHO/Stress Test ‰ Mammogram ‰ PFTs ‰ PapSmear ‰ Prior Intubations ‰ Radiation exposure ‰ Sleep Study ‰ Steroid use Family Medical History ‰ Asthma ‰ Malignancy ‰ Cystic fibrosis ‰ Sjogren’s ‰ Pancreatitis ‰ Scleroderma ‰ Sarcoidosis ‰ Rheumatoid arthritis Exposure to ‰ Hot tub , Sauna, Jacuzzi, Humdifier ‰ Chemicals ‰ Pressure washings ‰ Organic or inorganic dusts r inorganic ‰ Pets or feathers ‰ Fires Surgeries ‰Denies surgical history ‰ Tobacco ____ Packs x ____ Yrs ‰ Quit ‰ Recreational drug use, especially amphetamines, opiates or cocaine ‰ Alcohol _____ Drinks per day Occupations and Hobbies History of exposure to Inorganic dusts i.e., quarries, sandblasting, cement, stone carving, welding, plumbing, shipyard work, firefighter Organic dusts i.e., farming, building inspection, woodworking, remodeling, handling vegetable matter or animals Noxious fumes i.e., spray painting, autobody work, working with dyes or glues, manufacturing plastic Vaccines Travel history ‰Flu ‰Pneumo ‰BCG ‰Tetanus ‰Pertussis ‰Varicella İMB and RR 2006, 2007 Revised 24April07 Interstitial Lung Disease Evaluation Exam T P R BP Wt Sats ✔ Date Start time Stop time MRN ‰ Checked box indicates findings are within normal limits ‰ Alert *General ‰ Nasal mucosa ‰ Dentition ‰ Oropharynx Mallampati ‰I ‰II ‰III ‰ IV *ENT ‰ Normal to palpation ‰ Thyroid ‰ No JVD *Neck ‰ Clear to auscultation ‰ Clear to percussion ‰No respiratory distress ‰No chest wall defects *Resp ‰ Clear S1 S2 ‰ No murmur ‰ No gallop ‰No rub ‰ Periph pulses ‰ No peripheral edema *CV ‰No palpable masses ‰ No hepatosplenomegaly ‰ No hepatojugular reflux *GI ‰ No lymphadenopathy Lymph ‰Tone ‰ Gait Musc ‰ No clubbing ‰ No cyanosis Extrem ‰ No rashes, ecchymoses, nodules, ulcers Skin ‰ Oriented ‰Affect Neuro Impression/Plan DDx of interstitial lung disease includes, but is not limited to, x f interstitial Hypersensitivity Pneumonitis, Asbestosis, Slicosis, Coal Worker’s Pneumoconiosis, Mixed Dust Pneumoconiosis, y Pneumonitis, Silicosiderosis, Talcosis, Berylliosis, Hard-metal disease, Sarcoidosis, Sjogren’s, Rheumatoid lung, Carcinomatosis, Lymphangitic spread of malignancy, Nonspecific interstitial pneumonitis, Desquamative Interstitial Pneumonitis, Cryptogenic Organizing Pneumonia, Post-fibrotic phase of ARDS, Drug-induced lung Cryptogenic r f ARDS, disease, Allergic bronchopulmonary aspergillosis, Cystic fibrosis, Eosinophilic lung disease, Noncardiogenic pulmonary edema, Tuberous sclerosis, Infection, Idiopathic pulmonary fibrosis Labs/Tests This pt may benefit from ‰Pulmonary Function Testing ‰Chest CT ‰ECHO ‰CXR ‰Six Minute Walk Test ‰Cardiopulmonary Stress Test ‰Pneumococcal vaccine ‰Influenza vaccine ‰PPD Testing ‰Sputum cultures ‰Pulmonary Rehabilitation ‰Smoking cessation aids ‰Labs Signature/Date: Code Status ‰ Full code ‰ Do Not Attempt Resuscitation Data Reviewed: ‰ ER Notes ‰ Old Chart ‰Nursing Notes & Vitals log ‰ Labs ‰ Radiology data ‰ECHO ‰ECG ‰ Stress Test ‰ PFT ‰ Diabetic log ‰Discuss w/ER MD ‰Discuss w/HCPOA ‰Discuss w/PCP ‰Case Mgmt or SW ‰Pharmacy ‰Nutrition team ‰Physical therapy ‰Respiratory therapy ‰Nursing Revised 24April07 Coordination of care: İMB and RR 2006, 2007


    Template updated 2/8/08

    Template Features



    Buy ILD evaluation template now from REGNOW.COM


    Shopper Support


    Terms of Sale










 

ILD and the Healthcare System

Interstitial Lung Disease (ILD) is a diverse group of more than 200 diseases that cause progressive fibrosis (scarring) of lung tissue, which leads to chronic, progressive breathlessness and respiratory failure.  The Pulmonary Fibrosis Foundation (www.pulmonaryfibrosis.org) estimates that more than 200,000 Americans have ILD, and nearly 40,000 Americans die each year from ILD.  

ILD includes idiopathic pulmonary fibrosis (IPF), sarcoidosis, hypersensitivity pneumonitis, Nonspecific Interstitial Pneumonitis (NSIP), Desquamative
Interstitial Pneumonitis (DIP), Cryptogenic Organizing Pneumonia (COP, aka BOOP), medication induced lung disease, post-radiation fibrosis, and many other diseases.

The primary symptoms of ILD are nonspecific, such as non-productive cough and progressive breathlessness.  These symptoms are seen in many other medical conditions such as asthma, heart failure, or chronic obstructive pulmonary disease (COPD).   The lack of specificity of the presenting symptoms makes the identification of ILD challenging, particularly in individuals with known heart or lung disease.  Early and accurate diagnosis of ILD is essential so that treatment options can be considered before extensive and permanent damage occurs, resulting in disabling breathlessness.  While there is currently no proven, FDA-approved treatment for idiopathic pulmonary fibrosis, many forms of interstitial lung disease can be treated, if detected early in the disease process.  Thus, having a low threshold for suspecting interstitial disease, and assessing a patient’s risk of developing pulmonary fibrosis by obtaining important historical information is critical to early diagnosis. 


E & M Documentation Template

The interstitial lung disease evaluation MedicalTemplate contains prompters and space for all the required elements for a E&M encounter.  

Back to top>


Digital Health Record

The interstitial lung disease evaluation MedicalTemplate functions like all other PDF files, but they have editable text fields and working checkboxes.  This allows information to be typed in or pasted from other applications to fill out the template.

Filled interstitial lung disease evaluation MedicalTemplates can be printed and saved to a computer, USB drive, CD, DVD, or other storage device to create a digital health record for your patients.

To learn more about how MedicalTemplates can be used as a digital health record, click here.

Back to top> 



Digital Signature Enabled

The interstitial lung disease evaluation MedicalTemplate can be signed with a digital signature, instead of a handwritten signature, if the use of a digital signature is acceptable at your practice location.   Adobe PDF digital signatures require the creation of a digital ID that is used to sign the PDF.  

To learn more about Adobe PDF digital signatures, click here.

Back to top>






MedicalTemplates are in the Adobe PDF format, which requires the free Adobe Reader.  With Adobe Reader, these templates can be printed as many times as needed on paper meeting your specifications or the specifications of any clinic, hospital, or other health care facility.